MedPath

Effect of Moringa Oleifera Leaf on Hemoglobin Levels in Anemia

Phase 3
Completed
Conditions
Anemia of Pregnancy
Registration Number
NCT05737862
Lead Sponsor
Universitas Padjadjaran
Brief Summary

The main objective of this study was to compare the results of hemoglobin levels between pregnant women in the treatment group and the control group. Participants will be subjected to anthropometric measurements, recall of food intake for 1 x 24 hours, check hemoglobin before and after being given the intervention and participants in the treatment group are given moringa leaf capsules and iron tablets while participants in the control group are only given iron tablets. Researchers will compare the final results of hemoglobin levels between the treatment group and the control group

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • Pregnant women with 2nd and 3rd trimester of pregnancy
  • Pregnant women with mild to moderate anemia At day 90 after treatment

Exclusion Criteria :

  • Hypotensive pregnant women
  • Pregnant women with Gemelli
  • Pregnant women with chronic diseases (hepatitis and HIV)
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Changes in Haemoglobin (Hb) levelDay 0 and day 30

Hb will be meassured twice, before treatment and 30 days after treatment

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Padjajaran

🇮🇩

Bandung, West Java, Indonesia

University Padjajaran
🇮🇩Bandung, West Java, Indonesia

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.